Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Ischemic Heart Disease

  Free Subscription


Articles published in Prog Cardiovasc Dis

Retrieve available abstracts of 65 articles:
HTML format



Single Articles


    May 2020
  1. YOUSUF T, Nakhle A, Rawal H, Harrison D, et al
    Natural disasters and acute myocardial infarction.
    Prog Cardiovasc Dis. 2020 May 14. pii: S0033-0620(20)30099.
    PubMed     Abstract available


  2. DESAI AS, Kamdar BB, Mehra MR
    Palliative care considerations for cardiovascular clinicians in COVID-19.
    Prog Cardiovasc Dis. 2020 May 8. pii: S0033-0620(20)30098.
    PubMed    


  3. KRITTANAWONG C, Virk HUH, Narasimhan B, Wang Z, et al
    Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.
    Prog Cardiovasc Dis. 2020 May 7. pii: S0033-0620(20)30097.
    PubMed    


    April 2020
  4. ZHOU K, Yang S, Jia P
    Towards precision management of cardiovascular patients with COVID-19 to reduce mortality.
    Prog Cardiovasc Dis. 2020 Apr 27. pii: S0033-0620(20)30084.
    PubMed    


  5. SANTOS HO, Earnest CP, Tinsley GM, Izidoro LFM, et al
    Small dense low-density lipoprotein-cholesterol (sdLDL-C): Analysis, effects on cardiovascular endpoints and dietary strategies.
    Prog Cardiovasc Dis. 2020 Apr 27. pii: S0033-0620(20)30081.
    PubMed     Abstract available


  6. KARIO K, Ferdinand KC, O'Keefe JH
    Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease.
    Prog Cardiovasc Dis. 2020 Apr 7. pii: S0033-0620(20)30074.
    PubMed     Abstract available


  7. GARG A, Rout A, Sharma A, Sargsyan D, et al
    Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials.
    Prog Cardiovasc Dis. 2020 Apr 2. pii: S0033-0620(20)30072.
    PubMed     Abstract available


    March 2020
  8. DAS A, Roy B, Bandyopadhyay D, Dasgupta S, et al
    Non-statin interventions in the prevention of cardiovascular events: Sex-based meta-analysis.
    Prog Cardiovasc Dis. 2020 Mar 26. pii: S0033-0620(20)30064.
    PubMed     Abstract available


  9. LAVIE CJ
    Special assorted cardiovascular topics.
    Prog Cardiovasc Dis. 2020 Mar 26. pii: S0033-0620(20)30070.
    PubMed    


  10. GERSH F
    Benefits of estrogen in cardiovascular diseases.
    Prog Cardiovasc Dis. 2020 Mar 21. pii: S0033-0620(20)30062.
    PubMed    


  11. XU B, Kocyigit D, Griffin BP, Cheng F, et al
    Applications of artificial intelligence in multimodality cardiovascular imaging: A state-of-the-art review.
    Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30060.
    PubMed     Abstract available


  12. GULLO AL, Rodriguez-Carrio J, Gallizzi R, Imbalzano E, et al
    Speckle tracking echocardiography as a new diagnostic tool for an assessment of cardiovascular disease in rheumatic patients.
    Prog Cardiovasc Dis. 2020 Mar 19. pii: S0033-0620(20)30057.
    PubMed     Abstract available


    February 2020
  13. HAMILTON AB, Brown A, Loeb T, Chin D, et al
    Enhancing patient and organizational readiness for cardiovascular risk reduction among black and Latinx patients living with HIV: Study protocol.
    Prog Cardiovasc Dis. 2020 Feb 25. pii: S0033-0620(20)30054.
    PubMed     Abstract available


  14. AIFAH A, Okeke NL, Rentrope CR, Schexnayder J, et al
    Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics.
    Prog Cardiovasc Dis. 2020 Feb 21. pii: S0033-0620(20)30053.
    PubMed     Abstract available


  15. LONGENECKER CT, Webel AR, Lloyd-Jones DM
    Prevention as treatment: A bold vision for improving the cardiovascular health of people living with HIV.
    Prog Cardiovasc Dis. 2020 Feb 20. pii: S0033-0620(20)30051.
    PubMed    


  16. TAKADA S, Ober AJ, Currier JS, Goldstein NJ, et al
    Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial.
    Prog Cardiovasc Dis. 2020 Feb 18. pii: S0033-0620(20)30052.
    PubMed     Abstract available


  17. MANGIACAPRA F, Del Buono MG, Abbate A, Gori T, et al
    Role of endothelial dysfunction in determining angina after percutaneous coronary intervention: Learning from pathophysiology to optimize treatment.
    Prog Cardiovasc Dis. 2020 Feb 13. pii: S0033-0620(20)30039.
    PubMed     Abstract available


  18. MUIRURI C, Longenecker CT, Meissner EG, Okeke NL, et al
    Prevention of cardiovascular disease for historically marginalized racial and ethnic groups living with HIV: A narrative review of the literature.
    Prog Cardiovasc Dis. 2020 Feb 11. pii: S0033-0620(20)30036.
    PubMed     Abstract available


  19. OKELLO S, Amir A, Bloomfield GS, Kentoffio K, et al
    Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa.
    Prog Cardiovasc Dis. 2020 Feb 5. pii: S0033-0620(20)30034.
    PubMed     Abstract available


  20. WILLIAMS SK, Johnson BA, Tobin JN, Luque AE, et al
    Protocol paper: Stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV.
    Prog Cardiovasc Dis. 2020 Feb 5. pii: S0033-0620(20)30033.
    PubMed     Abstract available


    January 2020
  21. OZEMEK C, Erlandson KM, Jankowski CM
    Physical activity and exercise to improve cardiovascular health for adults living with HIV.
    Prog Cardiovasc Dis. 2020 Jan 31. pii: S0033-0620(20)30027.
    PubMed     Abstract available


    November 2019
  22. MARTINEZ-GOMEZ D, Lavie CJ, Hamer M, Cabanas-Sanchez V, et al
    Physical activity without weight loss reduces the development of cardiovascular disease risk factors - a prospective cohort study of more than one hundred thousand adults.
    Prog Cardiovasc Dis. 2019 Nov 20. pii: S0033-0620(19)30144.
    PubMed     Abstract available


  23. DZAYE O, Dudum R, Reiter-Brennan C, Kianoush S, et al
    Coronary artery calcium scoring for individualized cardiovascular risk estimation in important patient subpopulations after the 2019 AHA/ACC primary prevention guidelines.
    Prog Cardiovasc Dis. 2019 Nov 9. pii: S0033-0620(19)30132.
    PubMed     Abstract available


    October 2019
  24. MINAME MH, Santos RD
    Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
    Prog Cardiovasc Dis. 2019 Oct 25. pii: S0033-0620(19)30128.
    PubMed     Abstract available


    September 2019
  25. LAUKKANEN JA, Kunutsor SK, Ozemek C, Makikallio T, et al
    Cross-country skiing and running's association with cardiovascular events and all-cause mortality: A review of the evidence.
    Prog Cardiovasc Dis. 2019 Sep 7. pii: S0033-0620(19)30110.
    PubMed     Abstract available


    August 2019
  26. DEEDWANIA P
    Emerging strategies for diabetes and cardiovascular disorders: Introduction and foreword.
    Prog Cardiovasc Dis. 2019 Aug 27. pii: S0033-0620(19)30109.
    PubMed    


  27. ACHARYA T, Deedwania P
    Cardiovascular outcome trials of the newer anti-diabetic medications.
    Prog Cardiovasc Dis. 2019 Aug 20. pii: S0033-0620(19)30106.
    PubMed     Abstract available


  28. GARG V, Verma S, Connelly K
    Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes.
    Prog Cardiovasc Dis. 2019 Aug 2. pii: S0033-0620(19)30102.
    PubMed     Abstract available


  29. GODOY LC, Ko DT, Rao V, Farkouh ME, et al
    The Role of Coronary Artery Bypass Surgery Versus Percutaneous Intervention in Patients with Diabetes and Coronary Artery Disease.
    Prog Cardiovasc Dis. 2019 Aug 1. pii: S0033-0620(19)30101.
    PubMed     Abstract available


    July 2019
  30. LAVIE CJ
    Continuing with Good Statistics at Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2019 Jul 11. pii: S0033-0620(19)30099.
    PubMed    


  31. NELSON AJ, Peterson ED, Pagidipati NJ
    Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes.
    Prog Cardiovasc Dis. 2019 Jul 10. pii: S0033-0620(19)30098.
    PubMed     Abstract available


  32. GUPTA M, Tummala R, Ghosh RK, Blumenthal C, et al
    An update on pharmacotherapies in diabetic dyslipidemia.
    Prog Cardiovasc Dis. 2019;62:334-341.
    PubMed     Abstract available


    May 2019
  33. BOB-MANUEL T, Jenkins JS, Morin DP
    Non-arrhythmic causes of sudden death: A comprehensive review.
    Prog Cardiovasc Dis. 2019;62:265-271.
    PubMed     Abstract available


    February 2019
  34. NAUMAN J, Nes BM, Zisko N, Revdal A, et al
    Personal activity intelligence (PAI): A new standard in activity tracking for obtaining a healthy cardiorespiratory fitness level and low cardiovascular risk.
    Prog Cardiovasc Dis. 2019 Feb 21. pii: S0033-0620(19)30039.
    PubMed     Abstract available


  35. KIRKHAM AA, Beaudry RI, Paterson DI, Mackey JR, et al
    Curing breast Cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast Cancer.
    Prog Cardiovasc Dis. 2019 Feb 21. pii: S0033-0620(19)30034.
    PubMed     Abstract available


    January 2019
  36. KAMINSKY LA, Arena R, Ellingsen O, Harber MP, et al
    Cardiorespiratory Fitness and Cardiovascular Disease - the Past, Present, and Future.
    Prog Cardiovasc Dis. 2019 Jan 9. pii: S0033-0620(19)30002.
    PubMed     Abstract available


    November 2018
  37. OZEMEK C, Laddu DR, Lavie CJ, Claeys H, et al
    An Update on the Role of Cardiorespiratory Fitness, Structured Exercise and Lifestyle Physical Activity in Preventing Cardiovascular Disease and Health Risk.
    Prog Cardiovasc Dis. 2018 Nov 13. pii: S0033-0620(18)30220.
    PubMed     Abstract available


    July 2018
  38. AWERBACH JD, Krasuski RA, Camitta MGW
    Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?
    Prog Cardiovasc Dis. 2018 Jul 21. pii: S0033-0620(18)30151.
    PubMed     Abstract available


  39. ELAGIZI A, Kachur S, Lavie CJ, Carbone S, et al
    An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 Jul 5. pii: S0033-0620(18)30130.
    PubMed     Abstract available


  40. BARRY VW, Caputo JL, Kang M
    The Joint Association of Fitness and Fatness on Cardiovascular Disease Mortality: A Meta-Analysis.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30131.
    PubMed     Abstract available


  41. RUIZ JR, Martinez-Tellez B, Sanchez-Delgado G, Osuna-Prieto FJ, et al
    Role of Human Brown Fat in Obesity, Metabolism and Cardiovascular Disease: Strategies to Turn Up the Heat.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30129.
    PubMed     Abstract available


  42. ORTEGA FB, Lavie CJ
    Introduction and Update on Obesity and Cardiovascular Diseases 2018.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30137.
    PubMed    


    June 2018
  43. PICHE ME, Poirier P, Lemieux I, Despres JP, et al
    Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update.
    Prog Cardiovasc Dis. 2018 Jun 28. pii: S0033-0620(18)30122.
    PubMed     Abstract available


  44. ENGLISH WJ, Williams DB
    Metabolic and Bariatric Surgery: An Effective Treatment Option for Obesity and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 Jun 25. pii: S0033-0620(18)30121.
    PubMed     Abstract available


    May 2018
  45. CHIAVAROLI L, Nishi SK, Khan TA, Braunstein CR, et al
    Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-Analysis of Controlled Trials.
    Prog Cardiovasc Dis. 2018 May 25. pii: S0033-0620(18)30094.
    PubMed     Abstract available


  46. KAHLEOVA H, Levin S, Barnard ND
    Vegetarian Dietary Patterns and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30087.
    PubMed     Abstract available


  47. BITOK E, Sabate J
    Nuts and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 May 22. pii: S0033-0620(18)30092.
    PubMed     Abstract available


  48. SIEVENPIPER JL, Lavie CJ
    Dietary Prevention of Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 May 4. pii: S0033-0620(18)30085.
    PubMed    


    April 2018
  49. SALAS-SALVADO J, Becerra-Tomas N, Garcia-Gavilan JF, Bullo M, et al
    Mediterranean Diet and Cardiovascular Disease Prevention: What do We Know?
    Prog Cardiovasc Dis. 2018 Apr 17. pii: S0033-0620(18)30074.
    PubMed     Abstract available


  50. KIM ESH, Beckman JA
    Introduction to the Vascular Medicine Issue of Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 Apr 6. pii: S0033-0620(18)30069.
    PubMed    


  51. AGRAWAL V, Kim ESH
    Spontaneous Coronary Artery Dissection: Cardiac Manifestations of Vascular Disease.
    Prog Cardiovasc Dis. 2018 Apr 6. pii: S0033-0620(18)30067.
    PubMed     Abstract available


    March 2018
  52. ELAGIZI A, Lavie CJ, Marshall K, DiNicolantonio JJ, et al
    Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health: A Comprehensive Review.
    Prog Cardiovasc Dis. 2018 Mar 20. pii: S0033-0620(18)30061.
    PubMed     Abstract available


    February 2018
  53. KERNEIS M, Talib U, Nafee T, Daaboul Y, et al
    Triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2018 Feb 2. pii: S0033-0620(18)30028.
    PubMed     Abstract available


    January 2018
  54. EFFRON MB, Gibson CM
    The waxing and waning of antithrombotic therapy in cardiovascular disease - Where is the moon now?
    Prog Cardiovasc Dis. 2018 Jan 21. pii: S0033-0620(18)30032.
    PubMed    


  55. DINICOLANTONIO JJ, Liu J, O'Keefe JH
    Thiamine and cardiovascular disease: A literature review.
    Prog Cardiovasc Dis. 2018 Jan 19. pii: S0033-0620(18)30029.
    PubMed     Abstract available


  56. TANTRY U, Navarese EP, Myat A, Gurbel P, et al
    Selection of P2Y12 inhibitor in percutaneous coronary intervention and/or acute coronary syndrome.
    Prog Cardiovasc Dis. 2018 Jan 12. pii: S0033-0620(18)30020.
    PubMed     Abstract available


  57. ZEITOUNI M, Kerneis M, Nafee T, Collet JP, et al
    Anticoagulation in acute coronary syndrome-state of the art.
    Prog Cardiovasc Dis. 2018 Jan 12. pii: S0033-0620(18)30021.
    PubMed     Abstract available


  58. VIDULA MK, Secemsky EA, Yeh RW
    Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician.
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Abstract available


  59. EFFRON MB, Gibson CM
    Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience.
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Abstract available


  60. GOLWALA H, Bhatt DL
    The Timing of P2Y12 Inhibitor Initiation in the Treatment of ACS? Does the Evidence Exist in This Era?
    Prog Cardiovasc Dis. 2018;60.
    PubMed     Abstract available


    December 2017
  61. SARBACKER GB, Lusk KA, Kalich B
    Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease in Adults 80-Years-of-Age and Older.
    Prog Cardiovasc Dis. 2017 Dec 29. pii: S0033-0620(17)30168.
    PubMed    


  62. MOON JY, Franchi F, Rollini F, Angiolillo DJ, et al
    Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy.
    Prog Cardiovasc Dis. 2017 Dec 29. pii: S0033-0620(17)30166.
    PubMed     Abstract available


  63. SHARMA A, Garg A, Elmariah S, Drachman D, et al
    Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Prog Cardiovasc Dis. 2017 Dec 22. pii: S0033-0620(17)30165.
    PubMed     Abstract available


    November 2017
  64. KARIO K, Tomitani N, Kanegae H, Yasui N, et al
    Development of a New ICT-Based Multisensor Blood Pressure Monitoring System for Use in Hemodynamic Biomarker-Initiated Anticipation Medicine for Cardiovascular Disease: The National IMPACT Program Project.
    Prog Cardiovasc Dis. 2017 Nov 3. pii: S0033-0620(17)30142.
    PubMed     Abstract available


    September 2017
  65. HERMAN ME, O'Keefe JH, Bell DSH, Schwartz SS, et al
    Insulin Therapy Increases Cardiovascular Risk: Time for a Sea of Change in Type 2 Diabetes Treatment.
    Prog Cardiovasc Dis. 2017 Sep 25. pii: S0033-0620(17)30139.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: